You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 139 No. 10, October 1979 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (8)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Penicillinase-Resistant Penicillin/Gentamicin Synergism

Effect in Patients With Staphylococcus aureus Bacteremia

Lt Comdr J. Hamilton Licht, MC

Arch Intern Med. 1979;139(10):1094-1098.


Abstract

Gentamicin sulfate has been shown to enhance the effects of penicillinase-resistant penicillins against clinical isolates of Staphylococcus aureus in vitro, but the relevance of this observation to bacteremic patients is unclear. Therefore, serum samples from 14 patients with staphylococcal bacteremia were tested for growth inhibitory and bactericidal effects against the patients' own pathogen while they received a penicillinase-resistant penicillin alone, and again when gentamicin was added to the therapeutic regimen. Addition of gentamicin in vivo was associated with slight improvement in growth inhibitory activity but it caused profound increases in serum bactericidal activity. This effect could not be attributed to higher serum levels of penicillinase-resistant penicillin during gentamicin administration. Addition of gentamicin to penicillinase-resistant penicillin can lead to marked improvement in a patient's serum bactericidal activity against his own staphylococcal pathogen, and should be considered for any patient who does not respond to more conventional therapy.

(Arch Intern Med 139:1094-1098, 1979)



Author Affiliations

USN

From the Department of Medicine, The Johns Hopkins Hospital, Baltimore, and the Clinical Investigation Center, Naval Regional Medical Center, Oakland, Calif.


Footnotes

Accepted for publication Jan 31, 1979.

The opinions or assertions contained herein are the private ones of the author, and are not to be construed as official, or as reflecting the views of the Navy Department or of the naval service at large.

Reprint requests to Publications Office, Clinical Investigation Center, Naval Regional Medical Center, Oakland, CA 94627 (Dr Licht).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

The Emergence of Methicillin-Resistant Staphylococcus aureus Infections in United States Hospitals: Possible Role of the House Staff-Patient Transfer Circuit
HALEY et al.
ANN INTERN MED 1982;97:297-308.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1979 American Medical Association. All Rights Reserved.